In America, 80 percent of children diagnosed with cancer survive to adulthood, but the after-effects of treatment can be profound: physically, emotionally, and financially.
In his 2019 State of the Union address, the president pledged $500 million toward pediatric cancer research. However, the way forward still isn’t clear. What is the best use for that money? Is it enough?
The Atlantic explored the scientific innovations, policy proposals, and personal stories that define today’s fight for survivor-informed cures.